Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: A potential marker for gene therapy trials

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 185-191

  Mark Overholt, S ^a   Liu, Ta Jen ^a   Taylor, Dorothy L ^a   Wang, Mary ^a   El Naggar, Adel K ^a   Shillitoe, Ed ^b   Adler Storthz, Karen ^c   John, Lisa St ^c   Zhang, Wei Wei ^a   Roth, Jack A ^a   Clayman, Gary L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAG PEPTIDE; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE THERAPY; GROWTH INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASM, RESIDUAL; PEPTIDES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1842375673     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Calhoun, K. H., Fulmer, P., Weiss, R., and Hokanson, J. A. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope, 104: 1199-1205, 1994.
2. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 429-435, 1995.
3. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, M., and Sidransky, D. The incidence of p53 mutation increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
4. Field, J. K., Pavelic, Z. P., Spandidos, D. A., Stambrook, P. J., Jones, A. S., and Gluckman, J. L. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 119: 1118-1122, 1993.
5. Watling, D. L., Gown, A. M., and Coltrera, M. D. Overexpression of p53 in head and neck cancer. Head Neck, 14: 437-444, 1992.
6. Nylander, K., Stenling, R., Gustafsson, H., Zackrisson, B., and Roos, G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer (Phila.), 75: 87-93, 1995.
7. Pavelic, Z. P., Li, Y-Q., Stambrook, P. J., McDonald, J. S., Munck-Wikland, E., Pavelic, K., Dacic, S., Danilovic, Z., Pavelic, L., Mugge, R. E., Wilson, K., Nguyen, C., and Gluckman, J. L. Overexpression of p53 protein is common in premalignant head and neck lesions. Anti-cancer Res., 14: 2259-2266, 1994.
8. Maestro, R., Dolcetti, R., Gasparatto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., and Boiocchi, M. High frequency of p53 gene alterations associated with protein Overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159-1166, 1992.
9. Liu, T-J., Zhang, W-W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
10. Clayman, G. L., El-Naggar, A. K., Roth, J. A., Zhang, W-W., Goepfert, H., Taylor, D. L., and Liu, T-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
11. Baker, S. J., Markowitz, S., Fearon, E. R., Wilson, J. R., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
12. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Apella, E., Romano, J. W., and Ulrich, S. J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-Type p53. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
13. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwank, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, J. J., and Vogelstein, B. p53 functions as a cell cycle control protein in osteosarcoma, Mol. Cell. Biol., 10: 5772-5781, 1990.
14. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordet, B., and Costa, J. Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
15. Fujiwara, T., Grimm, E. A., Murkhopadhyay, T., Cal, D. W., Owen-Schaub, L. B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
16. Liu, T-J., El-Naggar, A. K., McDonnell, T. J., Steck, K. D., Wang, M., Taylor, D. L., and Clayman, G. L. Apoptosis induction mediated by wild-type p53 adenovirus gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
17. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
18. Hopp, T. P., Prickett, K. S., Price, V., Libby, R. T., March, C. J., Cerretti, P., Urdal, D. L., and Conlon, P. J. A short polypeptide marker sequence useful for identification and purification of recombinant proteins. Biotechnology, 7: 1205-1210, 1988.
19. Clayman, G. L., Wang, S. W., Nicholson, G. L., El-Naggar, A. K., Mazar, A., Henkins, J., Blasi, F., Goepfert, H., and Boyd, D. D. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity. Int. J. Cancer, 54: 73-80, 1993.
20. Sacks, P. G., Parnes, S. M., Gallick, G. E., Mansouri, Z., Lichtner, R., Satya-Prakash, K. L., Pathak, S., and Parsons, D. F. Establishment and characterization of two new squamous cell carcinoma cell lines derived From tumors of the head and neck. Cancer Res., 48: 2858-2866, 1988.
21. Zhang, W-W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53. I. Human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 1-10, 1994.
22. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
23. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
24. O'Malley, B. W., Jr., Chen, S-H., Schwartz, M. R., and Woo, S. L. C. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res., 55: 1080-1085, 1995.
25. Su, X., Prestwood, A. K., and McGraw, R. A. Production of recombinant porcine tumor necrosis factor a in a novel E. coli expression system. Biotechniques, 13: 756-761, 1992.
26. Wang, J., Bucana, C. D., Roth, J. A., and Zhang, W-W. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of AdCMV-p53. Cancer Gene Ther., 2: 1-9, 1995.
27. Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., and Rotter, V. Nuclear accumulation of p53 protein is mediated by several localization signals and plays a role in tumorigenesis. Mol. Cell Biol., 10: 6565-6577, 1990.